sample size in bioequivalence studies [Power / Sample Size]

posted by DavidManteigas – Portugal, 2017-08-03 14:40 (2894 d 17:26 ago) – Posting: # 17651
Views: 20,737

Hi daryazyatina,

For some reason, I can't see the image with the formula that you put on the first post.

❝ For comparison, I use all the standard properties. Design 2x2, confidence intervals 0.8 - 1.25, power 0.8, alpha 0.05.

❝ The only thing about what I'm not sure is CV. Because in formula that I used this is intra-subject variability, but in PowerTOST() this is coefficient of variation as ratio. In calculations in both cases I used СV - 0.3.


Within subject standard deviation and within subject CV are different parameters. Nevertheless, I think that this is not the only reason for such a big difference.

There is a sentence in one of the articles that is quoted on SampleNTOST formula that may clarify this issue:

"This formula is less conservative than Formula (5), but it may result in a lower actual power than the required. For example, when α = 0.05, σ = 0.3, Δ = 0.2, θ = 0.01 and a required power = 0.80, the sample size from Formula (6) [Formula from Chow] is 17 per sequence, but the actual power obtained by this sample size is only 0.69."

So by reading this, I am not sure if Chow formula might be appropriate to calculate sample size for BABE trials. I have just quickly read the article, so I may not be doing a proper analysis. Perhaps dlabes might clarify this, since he is the master that we all should thank for the amazing PowerTOST package :-D

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,680 registered users;
49 visitors (0 registered, 49 guests [including 15 identified bots]).
Forum time: 08:07 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5